OGEN.BC Insider Trading Activity and SEC Form 4 Filings
OGEN.BC insider trading summary
No open-market insider purchases or sales of Oragenics Inc (OGEN.BC) have been reported on SEC Form 4 in the past 12 months.
Latest OGEN.BC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 30, 2016 | Fred Telling | Director | Buy | $500K (969,180 @ $0.52) |
| Jun 30, 2016 | Koski Family LP | 10% Owner | Buy | $3.0M (5,815,080 @ $0.52) |
| Jun 30, 2016 | Christine L Koski | 10% Owner | Buy | $3.0M (5,815,080 @ $0.52) |
| Jun 30, 2016 | Beverly Koski | 10% Owner | Buy | $3.0M (5,815,080 @ $0.52) |
| Jun 30, 2016 | Robert C Koski | Director | Buy | $3.0M (5,815,080 @ $0.52) |
| Jun 30, 2016 | Thomas L Koski | 10% Owner | Buy | $3.0M (5,815,080 @ $0.52) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.